American Journal of Laboratory Medicine

| Peer-Reviewed |

Study of the Blood Count in Hospitalized Patients in the Dermatology Department of the CNAM

Received: 3 July 2018    Accepted: 16 July 2018    Published: 15 August 2018
Views:       Downloads:

Share This Article

Abstract

The blood count is the biological examination that aims to identify, count and observe the figured elements of the blood. In dermatology, the hemogram is an index of the evolution of the dermatosis and the general state of the patient. The blood count is the refore an examination that is of diagnostic and prognostic value in the management of dermatological conditions. Our objective was to determine the place of the blood count in the management of dermatosis in hospitalized patients of the CNAM. This was a descriptive cross-sectional study of all cases of hemogram performed in all hospitalized patients in the dermatology department of the CNAM during the period from January 1, 2015 to December 31, 2017, ie 3 years. The inclusion criteria were as follows: all inpatient records containing the hemogram results regardless of age and sex during the study period. Out Of the 133 cases included, 112 had abnormal blood counts, 84.2% of cases. Females accounted for 51.9% (69) and males 48.1% (64). The age of the patients ranged from 2 years to 90 years with an average age of 54.34 years. Among the hematological disorders observed: Anemia accounted for 86.6% of cases. It was hypochromic and microcytic in 80.4% of cases, normochromic and normocytic in 16.5% of cases and macrocytic normochromic in 3.1% of cases. This anemia was associated with chronic ulceration in almost 100% of cases, autoimmune bullous dermatosis (Pemphigus and Bullous Pemphigoid) in 72.7% of cases, erysipelas in 81.8% of cases, severe toxidermias in 75% of cases. erythroderma in 60.4% of cases, cutaneous carcinoma in 87.2% of cases. Leukocytosis accounted for 59.8% of cases. This leukocytosis was predominantly neutrophilic in 44.6% of cases, eosinophilic in 16.5% and lymphocytosis was observed in 14.6% of cases. This leukocytosis was associated with chronic ulceration in almost 44.2% of cases, with autoimmune bullous dermatoses (Pemphigus and Pemphigoid bullosa) in 81.6% of cases, with erysipelas in 63.6% of cases, with severe toxidermias in 74.5% of cases, with erythroderma in 60.2% of cases, cutaneous carcinomas in 66.3% of cases. the blood count remains the essential biological examination for the management and monitoring of severe dermatosis requiring hospitalization and our study could be a preliminary to other studies to elucidate its impact on the evolution of the dermatological disease.

DOI 10.11648/j.ajlm.20180303.11
Published in American Journal of Laboratory Medicine (Volume 3, Issue 3, May 2018)
Page(s) 30-33
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Study of the Blood Count, Hospitalized Patients, Department of Dermatology, CNAM

References
[1] A BISSEY A., MIGNONSIN D., VILASCO B., BONDURAND A., Contribution of the hemogram in the classification of anemias. Afr Black Med., 38 (11): 769-772, 1991.
[2] BERNARD J., LEVY J. P., VARET B., CLAUREL J. P., RAIN J. D. SULTANT Y.,. Hematology Abstracts, 9th edition; Paris: Manson. 1998.
[3] SWAANENBURG JCJM, RUTTEN WPF, ACJM HOLDRINET, VANSTRIK R. The determination of references for hematologic parameters using results obtained from patient populations. Am J Clin Pathol., 88: 182-91, 1987.
[4] French Society of Hematology, College of French Hematologists. Diagnosis, prognosis, treatment and surveillance of polycythemia. Consensus Conference, June 21, 1993. Paris: ANDEM, 1993.
[5] . Traoré A and col. Infectious dermatoses of the child in a dermatology department in a tropical environment (Burkina Faso). Burkina Medical Journal., 12 n02: 40-43, 1998.
[6] Y Fofana, A Dicko, 2, K Tall, et al. The reasons for hospitalization in children under 16 in Bamako. Journal of the Society of Clinical Biology of Benin., No. 027; 74-77, 2017.
[7] MAHE A., KEITA S., Faye O. et al. Handbook for the management of common skin diseases in Mali., p25, 2004.
[8] DALLMAN PR, YIP R, JONHSON C. Prevalence and causes of anemia in the United States, 1976 to 1980. Am J Clin Nutr., 39: 437-45, 1984.
[9] PIERARD g. E., E. CAUMES, FRANCIMONT C., ESTRADA J. A. Tropical Dermatology, Brussels, Editions of the University of Brussels., p 605, 1993.
[10] SANOU DM, KINDE-GAZARD D, VIGAN J, ADE G, SAHONOU JJ, ATADOKPEDE F and al. Clinical and immunological profite of HIV infected patients in Cotonou, Benin Med Mal Infect., 34: 225-28, 2004.
Cite This Article
  • APA Style

    Karabinta Yamoussa, Gassama Mamadou, Tall Kouressi, Cisse Lamissa, Gnossike Piham, et al. (2018). Study of the Blood Count in Hospitalized Patients in the Dermatology Department of the CNAM. American Journal of Laboratory Medicine, 3(3), 30-33. https://doi.org/10.11648/j.ajlm.20180303.11

    Copy | Download

    ACS Style

    Karabinta Yamoussa; Gassama Mamadou; Tall Kouressi; Cisse Lamissa; Gnossike Piham, et al. Study of the Blood Count in Hospitalized Patients in the Dermatology Department of the CNAM. Am. J. Lab. Med. 2018, 3(3), 30-33. doi: 10.11648/j.ajlm.20180303.11

    Copy | Download

    AMA Style

    Karabinta Yamoussa, Gassama Mamadou, Tall Kouressi, Cisse Lamissa, Gnossike Piham, et al. Study of the Blood Count in Hospitalized Patients in the Dermatology Department of the CNAM. Am J Lab Med. 2018;3(3):30-33. doi: 10.11648/j.ajlm.20180303.11

    Copy | Download

  • @article{10.11648/j.ajlm.20180303.11,
      author = {Karabinta Yamoussa and Gassama Mamadou and Tall Kouressi and Cisse Lamissa and Gnossike Piham and Sanogo Hawa and Dicko Adama and Sylla Ousmane and Kodio Mamadou and Bougoudogo Flabou and Faye Ousmane and Keita Somita and Diallo Dapa},
      title = {Study of the Blood Count in Hospitalized Patients in the Dermatology Department of the CNAM},
      journal = {American Journal of Laboratory Medicine},
      volume = {3},
      number = {3},
      pages = {30-33},
      doi = {10.11648/j.ajlm.20180303.11},
      url = {https://doi.org/10.11648/j.ajlm.20180303.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20180303.11},
      abstract = {The blood count is the biological examination that aims to identify, count and observe the figured elements of the blood. In dermatology, the hemogram is an index of the evolution of the dermatosis and the general state of the patient. The blood count is the refore an examination that is of diagnostic and prognostic value in the management of dermatological conditions. Our objective was to determine the place of the blood count in the management of dermatosis in hospitalized patients of the CNAM. This was a descriptive cross-sectional study of all cases of hemogram performed in all hospitalized patients in the dermatology department of the CNAM during the period from January 1, 2015 to December 31, 2017, ie 3 years. The inclusion criteria were as follows: all inpatient records containing the hemogram results regardless of age and sex during the study period. Out Of the 133 cases included, 112 had abnormal blood counts, 84.2% of cases. Females accounted for 51.9% (69) and males 48.1% (64). The age of the patients ranged from 2 years to 90 years with an average age of 54.34 years. Among the hematological disorders observed: Anemia accounted for 86.6% of cases. It was hypochromic and microcytic in 80.4% of cases, normochromic and normocytic in 16.5% of cases and macrocytic normochromic in 3.1% of cases. This anemia was associated with chronic ulceration in almost 100% of cases, autoimmune bullous dermatosis (Pemphigus and Bullous Pemphigoid) in 72.7% of cases, erysipelas in 81.8% of cases, severe toxidermias in 75% of cases. erythroderma in 60.4% of cases, cutaneous carcinoma in 87.2% of cases. Leukocytosis accounted for 59.8% of cases. This leukocytosis was predominantly neutrophilic in 44.6% of cases, eosinophilic in 16.5% and lymphocytosis was observed in 14.6% of cases. This leukocytosis was associated with chronic ulceration in almost 44.2% of cases, with autoimmune bullous dermatoses (Pemphigus and Pemphigoid bullosa) in 81.6% of cases, with erysipelas in 63.6% of cases, with severe toxidermias in 74.5% of cases, with erythroderma in 60.2% of cases, cutaneous carcinomas in 66.3% of cases. the blood count remains the essential biological examination for the management and monitoring of severe dermatosis requiring hospitalization and our study could be a preliminary to other studies to elucidate its impact on the evolution of the dermatological disease.},
     year = {2018}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Study of the Blood Count in Hospitalized Patients in the Dermatology Department of the CNAM
    AU  - Karabinta Yamoussa
    AU  - Gassama Mamadou
    AU  - Tall Kouressi
    AU  - Cisse Lamissa
    AU  - Gnossike Piham
    AU  - Sanogo Hawa
    AU  - Dicko Adama
    AU  - Sylla Ousmane
    AU  - Kodio Mamadou
    AU  - Bougoudogo Flabou
    AU  - Faye Ousmane
    AU  - Keita Somita
    AU  - Diallo Dapa
    Y1  - 2018/08/15
    PY  - 2018
    N1  - https://doi.org/10.11648/j.ajlm.20180303.11
    DO  - 10.11648/j.ajlm.20180303.11
    T2  - American Journal of Laboratory Medicine
    JF  - American Journal of Laboratory Medicine
    JO  - American Journal of Laboratory Medicine
    SP  - 30
    EP  - 33
    PB  - Science Publishing Group
    SN  - 2575-386X
    UR  - https://doi.org/10.11648/j.ajlm.20180303.11
    AB  - The blood count is the biological examination that aims to identify, count and observe the figured elements of the blood. In dermatology, the hemogram is an index of the evolution of the dermatosis and the general state of the patient. The blood count is the refore an examination that is of diagnostic and prognostic value in the management of dermatological conditions. Our objective was to determine the place of the blood count in the management of dermatosis in hospitalized patients of the CNAM. This was a descriptive cross-sectional study of all cases of hemogram performed in all hospitalized patients in the dermatology department of the CNAM during the period from January 1, 2015 to December 31, 2017, ie 3 years. The inclusion criteria were as follows: all inpatient records containing the hemogram results regardless of age and sex during the study period. Out Of the 133 cases included, 112 had abnormal blood counts, 84.2% of cases. Females accounted for 51.9% (69) and males 48.1% (64). The age of the patients ranged from 2 years to 90 years with an average age of 54.34 years. Among the hematological disorders observed: Anemia accounted for 86.6% of cases. It was hypochromic and microcytic in 80.4% of cases, normochromic and normocytic in 16.5% of cases and macrocytic normochromic in 3.1% of cases. This anemia was associated with chronic ulceration in almost 100% of cases, autoimmune bullous dermatosis (Pemphigus and Bullous Pemphigoid) in 72.7% of cases, erysipelas in 81.8% of cases, severe toxidermias in 75% of cases. erythroderma in 60.4% of cases, cutaneous carcinoma in 87.2% of cases. Leukocytosis accounted for 59.8% of cases. This leukocytosis was predominantly neutrophilic in 44.6% of cases, eosinophilic in 16.5% and lymphocytosis was observed in 14.6% of cases. This leukocytosis was associated with chronic ulceration in almost 44.2% of cases, with autoimmune bullous dermatoses (Pemphigus and Pemphigoid bullosa) in 81.6% of cases, with erysipelas in 63.6% of cases, with severe toxidermias in 74.5% of cases, with erythroderma in 60.2% of cases, cutaneous carcinomas in 66.3% of cases. the blood count remains the essential biological examination for the management and monitoring of severe dermatosis requiring hospitalization and our study could be a preliminary to other studies to elucidate its impact on the evolution of the dermatological disease.
    VL  - 3
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali; Department of Skin Disease, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Ministry of Higher Education and Scientific Research, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali; Department of Skin Disease, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Ministry of Higher Education and Scientific Research, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali

  • Biological Laboratory of the National Institute for Public Health Research, Ministry of Health, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali; Department of Skin Disease, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Ministry of Higher Education and Scientific Research, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali

  • Biological Laboratory of the National Institute for Public Health Research, Ministry of Health, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali; Department of Skin Disease, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Ministry of Higher Education and Scientific Research, Bamako, Mali

  • National Support Center for Disease Control (CNAM), Faculty of Medecine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali; Department of Skin Disease, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Ministry of Higher Education and Scientific Research, Bamako, Mali

  • Department of Skin Disease, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Ministry of Higher Education and Scientific Research, Bamako, Mali; 3Department of Hematology-Oncology at CHU Point G, Faculty of Medicine and Odontostomatology, University of the Sciences, Technics and Technology, Bamako, Mali

  • Sections